Inoviem Scientific approved by the French Ministry of Research for the Research Tax Credit «Crédit d’impôt recherche»
Strasbourg – November 2014.
Inoviem Scientific, as an innovative start-up company with cutting-edge technologies, has received the approval for the research Tax credit « Credit d’Impôt Recherche – CIR » from the French Ministry of Research. The CIR approval is delivered to companies performing research projects as the sign of recognition for their technical skills and know-how.
Any Pharma or biotech companies located in France can benefit from the research Tax credit (30% in 2014) for all services contracted with Inoviem Scientific.
With our expertise, experience and the CIR approval, Inoviem Scientific is known as an innovative, reliable and cost-effective partner to insure the progress of challenging drug development programs.
Please contact us for more information!